Lycke, J
624  results:
Search for persons X
?
1

Efficacy of prolonged-release fampridine versus placebo on ..:

Hupperts, R ; Gasperini, C ; Lycke, J...
Therapeutic Advances in Neurological Disorders, 15 (Art N° 175628642210903).  , 2023
 
?
2

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
Multiple Sclerosis and Related Disorders, 2211-0348, 2022, 68,.  , 2022
 
?
3

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
Multiple Sclerosis and Related Disorders, 2211-0348, 2022, 68,.  , 2022
 
?
4

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
Multiple Sclerosis and Related Disorders, 2211-0348, 2022, 68,.  , 2022
 
?
5

Smouldering multiple sclerosis: the 'real MS':

Giovannoni, G ; Popescu, V ; Wuerfel, J...
Giovannoni , G , Popescu , V , Wuerfel , J , Hellwig , K , Iacobeus , E , Jensen , M B , Garcia-Dominguez , J M , Sousa , L , De Rossi , N , Hupperts , R , Fenu , G , Bodini , B , Kuusisto , H M , Stankoff , B , Lycke , J , Airas , L , Granziera , C & Scalfari , A 2022 , ' Smouldering multiple sclerosis: the 'real MS' ' , Therapeutic Advances in Neurological Disorders , vol. 15 , 17562864211066751 . https://doi.org/10.1177/17562864211066751.  , 2022
 
?
6

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
https://acuresearchbank.acu.edu.au/item/8y97x/effectiveness-of-first-generation-disease-modifying-therapy-to-prevent-conversion-to-secondary-progressive-multiple-sclerosis.  , 2022
 
?
7

A multicentre validation study of the diagnostic value of p..:

Ashton, NJ ; Janelidze, S ; Al Khleifat, A...
https://discovery.ucl.ac.uk/id/eprint/10129615/1/s41467-021-23620-z.pdf.  , 2021
 
?
 
?
9

Exploring CSF neurofilament light as a biomarker for MS in ..:

Rosenstein, I ; Axelsson, M ; Novakova, L...
https://discovery.ucl.ac.uk/id/eprint/10133796/1/13524585211039104.pdf.  , 2021
 
?
10

Kappa free light chain index as a diagnostic biomarker in m..:

Rosenstein, I ; Rasch, S ; Axelsson, M...
https://discovery.ucl.ac.uk/id/eprint/10134459/1/Zetterberg_jnc.15500.pdf.  , 2021
 
?
11

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in M..:

Alping, P ; Askling, J ; Burman, J...
Annals of Neurology, 0364-5134, 2020, 87:5, s. 688-699.  , 2020
 
?
13

The serine protease HTRA1 increases in the brain and CSF in..:

Hjæresen, Simone ; Sejbæk, Tobias ; Axelsson, M...
Hjæresen , S , Sejbæk , T , Axelsson , M , Phil- Jensen , G , Jensen , H V , Kløvedal Mortensen , S , Pedersen , C B , Halle , B , Rom Poulsen , F , Zhang , M , Battistini , J L , Lycke , J , Illés , Z & Fex Svenningsen , Å 2020 , ' The serine protease HTRA1 increases in the brain and CSF in Multiple Sclerosis ' , Forskningsmøde , København , Denmark , 03/03/2020 - 03/03/2020 ..  , 2020
 
?
 
1-15